Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
نویسنده
چکیده
Organizations are trying to address the high cost of "specialty" medications that treat conditions such as cancer, hepatitis C, and multiple sclerosis. While comprising less than 1% of U.S. prescriptions, these drugs now account for 27% of pharmacy spending.
منابع مشابه
30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?
Background US drug prices are among the highest worldwide as US policy makers have historically been reluctant to embrace price regulations, instead relying on market forces to set prices. However, the introduction of a number of breakthrough, highly effective and high-cost specialty medicines over the past years has stoked the fire of the long-running drug price debate in the USA. The prices o...
متن کاملمدل پاسخ بار الکتریکی مبتنی بر برنامه‌ریزی تصادفی
Incorporating the demand response program (DRP) is one of the best approaches to increase the efficiency level and improving the competitive electricity market performance. In a competitive market, consumers can response to the wholesale market price variations during different time scale. The DRP allows the independent system operator to decrease the price volatility in peak hours. Different r...
متن کاملبازار مواد مخدر در ایران نگاهی ویژه به بازار تهران
This article reviews Iranian illicit drug market and also addresses the amount of consumption, type of consuming drugs as well as drug prices in Tehran’s market. To examine Iranian drug market, we have reviewed opium prices in Afghanistan and drug transition routes into the I. R. of Iran where some part of transited drugs are exported to Europe and United States of America. Owing to the fact t...
متن کاملA New Pharmaceutical Environment in Iran: Marketing Impacts
For nearly 25 years, Iranian Pharmaceutical market has been a closed and centrally controlled one. Although some initiatives have been introduced during the last decade, yet the system is characterized as a closed one and lacks real competition. The current situation of drug in Iran may be characterized as: Intense price control by the Drug Authority i.e. Ministry of Health Ban of d...
متن کاملPrivacy, Driving Data and Automobile Insurance: An Economic Analysis
With new technologies that enable insurers to electronically monitor vehicles and drivers, insurers should be able to price automobile insurance more accurately, creating individualized prices for consumers. The welfare effects of lower prices are straightforward, but we also consider that consumers have heterogeneous valuations of privacy that they may lose if they adopt the monitoring technol...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 39 8 شماره
صفحات -
تاریخ انتشار 2014